MEGAN MELOY: Open Payments
NPI 1184114274 · CHESTERFIELD, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$969 in 46 payments from 17 companies in 2025. Trend: 2023 $1,378 · 2024 $878 · 2025 $969
Food & beverage: $969
| Company | Payments | Amount |
|---|---|---|
| Evofem Biosciences, Inc. | 7 | $133 |
| Sage Therapeutics, LLC | 5 | $112 |
| MAYNE PHARMA COMMERCIAL LLC | 5 | $106 |
| Sumitomo Pharma America, Inc. | 5 | $105 |
| MILLICENT US INC | 5 | $100 |
| Astellas Pharma US Inc | 3 | $75 |
| Novo Nordisk Inc | 4 | $67 |
| ABBVIE INC. | 2 | $55 |
| Dexcom, Inc. | 2 | $47 |
| Baxter Healthcare | 1 | $30 |
Products named: Phexxi, ZURZUVAE, Veozah, MYFEMBREE, FEMLYV, UBRELVY, Dexcom G6 Transmitter, INTRAROSA.
Industry payments across MO — which companies pay providers there.
